Latest Post

June 07, 2021

Robust CCI Performance Evaluation Through a New Integrated Approach

Container closure integrity (CCI) has been a fundamental core requirement of containment and delivery solutions in the West product portfolio. Container closure systems (CCSs) must maintain both the sterility and stability of pharmaceutical products; very importantly they must be free of microbial contamination. Microbial ingress into a CCS will jeopardize product sterility.
Qingyu Zeng

Qingyu Zeng, Ph.D.

Fellow and Technical Director

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    Stoppers

    November 20, 2020

    New USP Chapters , , , and

    Daniel Bantz

    Daniel Bantz

    Manager, Scientific Communications, Self Injection Systems

    Stoppers

    August 03, 2020

    Elastomer Stoppers – Performance

    Mary Tan

    Mary Tan

    Specialist, Scientific Affairs, Jurong

    Capped Vials

    December 09, 2019

    Evaluation of Container Systems with Residual Seal Force (RSF)

    Mary Tan

    Mary Tan

    Specialist, Scientific Affairs, Singapore, Jurong

    Analytics

    August 22, 2019

    What’s New in the Knowledge Center? Data Analytics

    Tara Haarlander

    Tara Haarlander

    Sr. Specialist, Scientific Communications

    A nurse extracting a medication from a vial into a syringe

    June 04, 2019

    Are You Ready? Compliance with New USP Chapters <381>, <382>, <1381> and <1382>

    Daniel Bantz

    Daniel Bantz

    Technical Manager, Packaging & Performance, Laboratory

    Load more